Use of Truveta Data in CDC Study Underscores Real-World Evidence Potential

According to a recent LinkedIn post from Truveta, a CDC-led study using Truveta Data suggests that the timing of clinic visits may affect whether patients fill and adhere to antihypertensive prescriptions. The analysis of more than 4 million prescriptions reportedly found lower fill and 90-day adherence rates for patients seen later in the day, implying operational factors may influence medication management.

The post highlights Truveta’s role as a data provider for large-scale clinical research, underscoring the potential value of its dataset for public health and healthcare optimization studies. For investors, this kind of research use case may signal growing demand for Truveta’s analytics capabilities from government and health-system partners, potentially strengthening its positioning in real-world evidence and data-as-a-service markets.